2024. Immunogenicity and safety of Cervarix HPV-16/18 AS04-adjuvant vaccine against HPV induced cervical cancer in women (15+ years). UCC Student Medical Journal. 3, (Oct. 2024), 50–61. DOI:https://doi.org/10.33178/SMJ.2023.1.5.